DDP-24, or "DDP-24: The Drug Development Pipeline," is a classification and framework often used in the pharmaceutical and biotechnology industries to describe various stages of drug development. The term can refer more generally to a specific initiative, program, or framework that focuses on the development and regulatory processes for potential new medications.
Articles by others on the same topic
There are currently no matching articles.